Tubulis Therapeutics
Tubulis Therapeutics is a Munich-based therapeutics company developing matched protein-drug conjugates.
4
Funding Rounds
$90.5m
Money raised
Overview
Tubulis Therapeutics is a Munich-based therapeutics company developing matched protein-drug conjugates.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Do***** Sc******** | - | - | |
| Jo*** He*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Tubulis Therapeutics has raised a total of $75.3m in funding over 4 rounds.
Key Insights:
- Tubulis Series B round, May 2022: $63m
- Tubulis Therapeutics Series A round, July 2020: $12.3m
- Tubulis Therapeutics Series A Funding Round July 2020: $13.5m
- Tubulis Therapeutics Grant July 2017: $1.67m
Tubulis Series B round, May 2022
$63m
Tubulis Therapeutics Series A round, July 2020
$12.3m
Tubulis Therapeutics Grant July 2017
$1.67m
Tubulis Therapeutics Series A Funding Round July 2020
$13.5m
Industries
Tubulis Therapeutics is active in the following industries: